Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 21, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of share transactions rather than a financial performance report.
Material Changes
The filing details specific transfers of Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- August 17, 2006: Transfer of 14,130 Ordinary Shares.
- August 18, 2006: Transfer of 8,100 Ordinary Shares.
These transactions were advised to the Company on August 21, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Verify the total number of shares transferred (22,230) against the Company's employee share plan records.
- Confirm the impact of these transfers on the outstanding share count and potential dilution.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand vesting conditions.